Results 171 to 180 of about 7,423,179 (348)

Residual decontamination chemical agents negatively affect adhesion and proliferation of osteoblast-like cells on implant surface. [PDF]

open access: yesInt J Implant Dent, 2020
Balderrama ÍF   +6 more
europepmc   +1 more source

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

open access: yesMolecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee   +8 more
wiley   +1 more source

Chemical warfare agents

open access: yesContinuing Education in Anaesthesia Critical Care & Pain, 2006
James Geoghegan, Jeffrey L Tong
openaire   +1 more source

ACEGEN: Reinforcement Learning of Generative Chemical Agents for Drug Discovery. [PDF]

open access: yesJ Chem Inf Model
Bou A   +12 more
europepmc   +1 more source

New chemical agents based on adamantane-monoterpene conjugates against orthopoxvirus infections. [PDF]

open access: yesRSC Med Chem, 2020
Suslov EV   +10 more
europepmc   +1 more source

Efficacy of adjunctive anti-plaque chemical agents in managing gingivitis: a systematic review and meta-analysis.

open access: yesJournal of Clinical Periodontology, 2015
J. Serrano   +4 more
semanticscholar   +1 more source

Targeting p38α in cancer: challenges, opportunities, and emerging strategies

open access: yesMolecular Oncology, EarlyView.
p38α normally regulates cellular stress responses and homeostasis and suppresses malignant transformation. In cancer, however, p38α is co‐opted to drive context‐dependent proliferation and dissemination. p38α also supports key functions in cells of the tumor microenvironment, including fibroblasts, myeloid cells, and T lymphocytes.
Angel R. Nebreda
wiley   +1 more source

Editorial: Metals in medicine

open access: yesFrontiers in Chemistry, 2022
Zhe Liu, Christian Hartinger, Nora Kulak
doaj   +1 more source

Basroparib inhibits YAP‐driven cancers by stabilizing angiomotin

open access: yesMolecular Oncology, EarlyView.
Basroparib, a selective tankyrase inhibitor, suppresses Wnt signaling and attenuates YAP‐driven oncogenic programs by stabilizing angiomotin. It promotes AMOT–YAP complex formation, enforces cytoplasmic YAP sequestration, inhibits YAP/TEAD transcription, and sensitizes YAP‐active cancers, including KRAS‐mutant colorectal cancer, to MEK inhibition.
Young‐Ju Kwon   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy